ZHEJIANG TOP MEDICINE CO.,ltd

Top Medicine is mainly in the business of developing, mafanucturing and distribution of in vitro diagnostic strips or kits, active pharmaceutical ingredients and intermediates. A growth engine has been started and a series of in vitro diagnostic strips / kits has been developed and marketed. In the following 5 years, a wider array of products ranging from monoclonal antibody immunoassay strips and medical devices to DNA recombinant products, DNA chips and biosensors will be launched. Another growth focus is pharmaceutical sector. D-Dihydrophenylglycine Sodium Dane Salt, a key intermediate for Cefradine, enjoys the largest capacity in China, up to 1,000 tons, and a 50% market share in China. (Z)-2-methoxyimno-furyl-acetic acid ammonium salt (SMIA) and 3-hydroxy-1-adamantaneamine (intermediate for Vildagliptin) are two newly developed intermediates and enjoy great market potentials. Top Medicine is living up to its commitments of manufacturing Calcium Polycarbophil, an API for human health, in accordance with presented dossier and cGMP practice. Top Medicine is developing itself by fully utilizing its resources and innovation efforts and optimizing product structure. With an aim to grow into a group pharmaceutical company in the following 5 years, all employees are working with great enthusiasm and proactive attitudes to fulfill the goals of profits, product and customer service, interest of shareholders and employees, and quality management. Top persists on the principles of developing itself while focusing on customer value-based service and shareholder interest-oriented business activities, voluntarily shouldering its social responsibilities and establishing pipelines for personal development.